Oncolytics Biotech® to Host Conference Call to Discuss Third Quarter Financial Results and Recent Operational Highlights
Oncolytics Biotech will host a conference call and webcast on Tuesday, November 12, 2024, at 8:30 a.m. ET to discuss its third-quarter 2024 financial results and recent operational highlights. The event will be accessible via North American toll-free number (888) 510-2154 and international number (437) 900-0527. Participants can also join through RapidConnect or access the webcast on the Investor Relations page of Oncolytics' website. The webcast will be archived for three months, with a dial-in replay available for one week at (888) 660-6345 (North America) or (289) 819-1450 (International) using replay code 68336#.
Oncolytics Biotech organizzerà una chiamata conferenza e webcast martedì, 12 novembre 2024, alle 8:30 a.m. ET per discutere i suoi risultati finanziari del terzo trimestre 2024 e le recenti evidenze operative. L'evento sarà accessibile attraverso il numero verde nordamericano (888) 510-2154 e il numero internazionale (437) 900-0527. I partecipanti potranno anche unirsi tramite RapidConnect o accedere al webcast nella pagina Relazioni con gli Investitori del sito web di Oncolytics. Il webcast sarà archiviato per tre mesi, con una riproduzione disponibile per una settimana al numero (888) 660-6345 (Nord America) o (289) 819-1450 (Internazionale) utilizzando il codice di replay 68336#.
Oncolytics Biotech llevará a cabo una llamada de conferencia y webcast el martes 12 de noviembre de 2024 a las 8:30 a.m. ET para discutir sus resultados financieros del tercer trimestre de 2024 y los aspectos destacados operativos recientes. El evento será accesible a través del número gratuito para América del Norte (888) 510-2154 y el número internacional (437) 900-0527. Los participantes también pueden unirse a través de RapidConnect o acceder al webcast en la página de Relaciones con Inversores del sitio web de Oncolytics. El webcast se archivará durante tres meses, con una reproducción de llamada disponible por una semana al (888) 660-6345 (América del Norte) o (289) 819-1450 (Internacional) utilizando el código de reproducción 68336#.
Oncolytics Biotech는 2024년 11월 12일 화요일 오전 8시 30분 ET에 2024년 3분기 재무 결과 및 최근 운영 하이라이트에 대해 논의하는 컨퍼런스 콜 및 웹캐스트를 개최합니다. 이 행사는 북미 무료전화번호 (888) 510-2154와 국제번호 (437) 900-0527를 통해 접근할 수 있습니다. 참가자는 RapidConnect를 통해 참석하거나 Oncolytics 웹사이트의 투자자 관계 페이지에서 웹캐스트에 접속할 수도 있습니다. 웹캐스트는 3개월 동안 보관되며, (888) 660-6345 (북미) 또는 (289) 819-1450 (국제)에서 68336# 재생 코드를 사용하여 1주일 동안 다시 듣기 서비스를 이용할 수 있습니다.
Oncolytics Biotech organisera une conférence téléphonique et un webcast le mardi 12 novembre 2024 à 8h30 ET pour discuter de ses résultats financiers du troisième trimestre 2024 et des points saillants récents de ses opérations. L'événement sera accessible via le numéro gratuit nord-américain (888) 510-2154 et le numéro international (437) 900-0527. Les participants peuvent également se joindre via RapidConnect ou accéder au webcast sur la page de Relations Investisseurs du site web d'Oncolytics. Le webcast sera archivé pendant trois mois, avec une rediffusion par téléphone disponible pendant une semaine au (888) 660-6345 (Amérique du Nord) ou au (289) 819-1450 (international) en utilisant le code de rediffusion 68336#.
Oncolytics Biotech wird am Dienstag, den 12. November 2024 um 8:30 Uhr ET eine Telefonkonferenz und einen Webcast abhalten, um über die Finanzergebnisse des dritten Quartals 2024 und aktuelle operationale Highlights zu diskutieren. Die Veranstaltung ist über die nordamerikanische gebührenfreie Nummer (888) 510-2154 und die internationale Nummer (437) 900-0527 zugänglich. Teilnehmer können auch über RapidConnect teilnehmen oder den Webcast auf der Investor Relations Seite der Website von Oncolytics abrufen. Der Webcast wird drei Monate lang archiviert, und ein telefonischer Rückblick ist eine Woche lang unter (888) 660-6345 (Nordamerika) oder (289) 819-1450 (International) mit dem Rückblick-Code 68336# verfügbar.
- None.
- None.
Conference call and webcast to take place on Tuesday, November 12, 2024, at 8:30 a.m. ET
Conference Call & Webcast
Date: Tuesday, November 12, 2024
Time: 8:30 a.m. ET
Dial In – North American Toll-Free: (888) 510-2154
Dial In – International: (437) 900-0527
RapidConnect: to join the conference call without operator assistance, please click here
Conference ID (if needed): 68336
Webcast: please click here
A webcast of the call will also be available on the Investor Relations page of Oncolytics' website, available by clicking here, and will be archived for three months. A dial-in replay will be available for one week and can be accessed by dialing (888) 660-6345 (
About Oncolytics Biotech Inc.
Oncolytics is a clinical-stage biotechnology company developing pelareorep, an intravenously delivered immunotherapeutic agent. Pelareorep has demonstrated promising results in two randomized Phase 2 studies in metastatic breast cancer and Phase 1 and 2 studies in pancreatic cancer. It acts by inducing anti-cancer immune responses and promotes an inflamed tumor phenotype -- turning "cold" tumors "hot" -- through innate and adaptive immune responses to treat a variety of cancers.
Pelareorep has demonstrated synergies with multiple approved oncology treatments. Oncolytics is currently conducting and planning combination clinical trials with pelareorep in solid and hematological malignancies as it advances towards registrational studies in metastatic breast cancer and pancreatic cancer, both of which have received Fast Track designation from the FDA. For further information, please visit: www.oncolyticsbiotech.com or follow the company on social media on LinkedIn and on X @oncolytics.
Company Contact Jon Patton Director of IR & Communication jpatton@oncolytics.ca | Investor Relations for Oncolytics Timothy McCarthy LifeSci Advisors +1-917-679-9282 |
Logo - https://mma.prnewswire.com/media/2408622/Oncolytics_Biotech_Inc_Logo.jpg
View original content to download multimedia:https://www.prnewswire.com/news-releases/oncolytics-biotech-to-host-conference-call-to-discuss-third-quarter-financial-results-and-recent-operational-highlights-302301016.html
SOURCE Oncolytics Biotech® Inc.
FAQ
When is Oncolytics Biotech's conference call to discuss Q3 2024 financial results?
How can I access Oncolytics Biotech's Q3 2024 financial results webcast?
What is the dial-in number for Oncolytics Biotech's Q3 2024 financial results call?
How long will the webcast of Oncolytics Biotech's Q3 2024 financial results be available?
What is the replay code for Oncolytics Biotech's Q3 2024 financial results call?
